United States · How much has GnuBIO raised?
GnuBIO has raised $23M across 4 rounds since 2010.
20112012
$3.0MSeries A$5.0MSeries A$4.5MGrant$10MSeries B
United States · Series B startup
Who invested in GnuBIO
4 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow GnuBIO and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$23Mraised across 4 rounds since 2010, from 4 sources
$3.0MSeries A$5.0MSeries A$4.5MGrant$10MSeries B
- Latest round
- Series B, $10MOct 2012
- Step-upi
- 2.2×
- Investors
- 0
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $3.0M Dec 2010
- Biggest round
- $10M Series B · Oct 2012
- Usual gap between rounds
- 13 months the median of 2
The rounds
- Oct 2012Series B$10M
No investor was named in the report.
Reported by masshightech.comSEC filing: $10M sold, first sale Sept 2012
- Sept 2012Grant$4.5M
No investor was named in the report.
Reported by masshightech.comSEC filing: $10M sold, first sale Sept 2012
- Sept 2011Series A$5.0M
No investor was named in the report.
Reported by sec.govSEC filing: $8.0M sold, first sale Nov 2010
- Dec 2010Series A$3.0M
No investor was named in the report.
Reported by masshightech.comSEC filing: $3.0M sold, first sale Nov 2010
Funding filed with regulators
GnuBIO filed 2 raises, $18M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Sept 2012$10MSEC Form D
- Nov 2010$8.0MSEC Form D
Founders and team
From the SEC filings it signed: 2 on the team.
- David WeitzExecutive Officer, Directori
- John BoyceExecutive Officer, Directori
On the board, as filediDavid BianchiMarie-Claude Bernal
The exit
ExitBuyerPriceWhen
AcquiredBio-Rad LaboratoriesundisclosedApr 2014
From historical deal records. Wrong? Tell us.
Quick answers about GnuBIO
When did GnuBIO last raise?
GnuBIO's most recent round was a Series B of $10M in Oct 2012.
What was GnuBIO's biggest round?
Its most recent round, $10M in Oct 2012, is also its largest on record.
What stage is GnuBIO at?
GnuBIO's latest named round is a Series B, in Oct 2012.
Where is GnuBIO based?
GnuBIO is based in the United States.
Companies like GnuBIO
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.